Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the Litx platform is safe and effective in
the treatment of liver metastasis arising from colorectal cancer. Litx is a next-generation
photodynamic therapy platform in which the drug, talaporfin sodium (LS11), is activated by
light from the light-emitting diode (LED)-based light infusion device, inserted directly into
the tumor through the skin prior to treatment.